메뉴 건너뛰기




Volumn 20, Issue 1, 2009, Pages 64-67

Acute profound thrombocytopenia with second exposure to eptifibatide associated with a strong antibody reaction

Author keywords

Eptifibatide; Immune thrombocytopenia; Thrombocytopenia

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; ENOXAPARIN; EPTIFIBATIDE; HEPARIN; HIRULOG; HYPERTENSIVE FACTOR;

EID: 61649127808     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.1080/09537100802592676     Document Type: Article
Times cited : (9)

References (15)
  • 1
    • 34548545280 scopus 로고    scopus 로고
    • Anderson JL, Adams CD. et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): Developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation 2007;116:e148-304.
    • Anderson JL, Adams CD. et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): Developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation 2007;116:e148-304.
  • 2
    • 34547789273 scopus 로고    scopus 로고
    • Drug-induced immune thrombocytopenia
    • Aster RH, Bougie DW. Drug-induced immune thrombocytopenia. N Engl J Med 2007;357:580-587.
    • (2007) N Engl J Med , vol.357 , pp. 580-587
    • Aster, R.H.1    Bougie, D.W.2
  • 3
    • 0033925843 scopus 로고    scopus 로고
    • Occurrence and clinical significance of pseudothrombocytopenia during abciximab therapy
    • Sane DC, Damaraju LV, Topol EJ. et al. Occurrence and clinical significance of pseudothrombocytopenia during abciximab therapy. J Am Coll Cardiol 2000;36:75-83.
    • (2000) J Am Coll Cardiol , vol.36 , pp. 75-83
    • Sane, D.C.1    Damaraju, L.V.2    Topol, E.J.3
  • 4
    • 33646016570 scopus 로고    scopus 로고
    • Thromobocytopenia associated with the use of GPIIb/IIIa inhibitors: Position paper of the ISTH working group on thrombocytopenia and GPIIb/IIIa inhibitors
    • Aster RH, Curtis BR, Bougie DW. et al. Thromobocytopenia associated with the use of GPIIb/IIIa inhibitors: Position paper of the ISTH working group on thrombocytopenia and GPIIb/IIIa inhibitors. J Thromb Haemost 2006;4:678-679.
    • (2006) J Thromb Haemost , vol.4 , pp. 678-679
    • Aster, R.H.1    Curtis, B.R.2    Bougie, D.W.3
  • 5
    • 0037105428 scopus 로고    scopus 로고
    • Acute thrombocytopenia after treatment with tirofiban or eptifibatide is associated with antibodies specific for ligand-occupied GPIIb/IIIA
    • Bougie DW, Wilker PR, Wuitschick ED. et al. Acute thrombocytopenia after treatment with tirofiban or eptifibatide is associated with antibodies specific for ligand-occupied GPIIb/IIIA. Blood 2002;100:2071-2076.
    • (2002) Blood , vol.100 , pp. 2071-2076
    • Bougie, D.W.1    Wilker, P.R.2    Wuitschick, E.D.3
  • 6
    • 2242477091 scopus 로고
    • Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty
    • The EPIC Investigators
    • The EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994;330:956-961.
    • (1994) N Engl J Med , vol.330 , pp. 956-961
  • 7
    • 31144479574 scopus 로고    scopus 로고
    • Frequency and management of thrombocytopenia with glycoprotein IIb/IIIa Receptor antagonists
    • Huxtable LM, Tafreshi MJ, Rakkar AN. Frequency and management of thrombocytopenia with glycoprotein IIb/IIIa Receptor antagonists. Am J Cardiol 2006;97:426-429.
    • (2006) Am J Cardiol , vol.97 , pp. 426-429
    • Huxtable, L.M.1    Tafreshi, M.J.2    Rakkar, A.N.3
  • 8
  • 9
    • 6344274868 scopus 로고    scopus 로고
    • Delayed thrombocytopenia after treatment with abciximab: A distinct clinical entity associated with the immune response to the drug
    • Curtis BR, Divgi A, Garritty M, Aster RH. Delayed thrombocytopenia after treatment with abciximab: A distinct clinical entity associated with the immune response to the drug. J Thromb Haemost 2004;2:985-992.
    • (2004) J Thromb Haemost , vol.2 , pp. 985-992
    • Curtis, B.R.1    Divgi, A.2    Garritty, M.3    Aster, R.H.4
  • 10
    • 61649100831 scopus 로고    scopus 로고
    • Package insert. ReoPro abciximab, Indianapolis: Eli Lilly, 2002
    • Package insert. ReoPro (abciximab). Indianapolis: Eli Lilly, 2002.
  • 11
    • 0008926519 scopus 로고    scopus 로고
    • Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes
    • The PURSUIT Trial Investigators
    • The PURSUIT Trial Investigators. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. N Engl J Med 1998;339:436-443.
    • (1998) N Engl J Med , vol.339 , pp. 436-443
  • 12
    • 0037369974 scopus 로고    scopus 로고
    • Acute profound thrombocytopenia associated with eptifibatide therapy
    • Nagge J, Jackevicius C, Dzavik V. et al. Acute profound thrombocytopenia associated with eptifibatide therapy. Pharmacotherapy 2003;23:374-379.
    • (2003) Pharmacotherapy , vol.23 , pp. 374-379
    • Nagge, J.1    Jackevicius, C.2    Dzavik, V.3
  • 13
    • 33845243141 scopus 로고    scopus 로고
    • Delayed profound thrombocytopenia associated with eptifibatide
    • Onitilo AA. Delayed profound thrombocytopenia associated with eptifibatide. Am J Hematol 2006;81:984.
    • (2006) Am J Hematol , vol.81 , pp. 984
    • Onitilo, A.A.1
  • 14
    • 13544250803 scopus 로고    scopus 로고
    • Immune thrombocytopenia caused by glycoprotein IIb/IIIa inhibitors
    • Aster RH. Immune thrombocytopenia caused by glycoprotein IIb/IIIa inhibitors. Chest 2005;127(2 Suppl):53S-59S.
    • (2005) Chest , vol.127 , Issue.2 SUPPL.
    • Aster, R.H.1
  • 15
    • 0032873921 scopus 로고    scopus 로고
    • Platelet activation as a potential mechanisim of GP IIb/IIa inhibitor - induced thrombocytopenia
    • Karlheinz P. et al. Platelet activation as a potential mechanisim of GP IIb/IIa inhibitor - induced thrombocytopenia. Am J Cardiol 1999;84:519-524.
    • (1999) Am J Cardiol , vol.84 , pp. 519-524
    • Karlheinz, P.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.